Social and contextual memory impairments induced by Amyloid-β oligomers are rescued by Sigma-1 receptor activation

IF 7.5 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Biomedicine & Pharmacotherapy Pub Date : 2025-02-24 DOI:10.1016/j.biopha.2025.117914
Souhail Djebari, Raquel Jiménez-Herrera, Guillermo Iborra-Lázaro, Lydia Jiménez-Díaz , Juan D. Navarro-López
{"title":"Social and contextual memory impairments induced by Amyloid-β oligomers are rescued by Sigma-1 receptor activation","authors":"Souhail Djebari,&nbsp;Raquel Jiménez-Herrera,&nbsp;Guillermo Iborra-Lázaro,&nbsp;Lydia Jiménez-Díaz ,&nbsp;Juan D. Navarro-López","doi":"10.1016/j.biopha.2025.117914","DOIUrl":null,"url":null,"abstract":"<div><div>Sigma-1 receptors (S1Rs) are widely expressed throughout the central nervous system and modulate neuron intracellular calcium levels, leading to changes in neurotransmitter release and neuronal activity. They also interact with various proteins and signaling pathways, playing a key role in regulating synaptic plasticity in brain areas such as the hippocampus, thereby influencing learning and memory processes. This opens a research avenue to explore S1R modulation as a potential therapeutic target in diseases involving hippocampal synaptic alterations and compromised cognitive processes, such as Alzheimer's disease (AD). Here, we hypothesize that pharmacological activation of S1R could counteract synaptic plasticity deficits and hippocampal-dependent cognitive alterations in an early-stage amyloidosis model of Alzheimer’s disease, induced by intracerebroventricular (<em>icv</em>) administration of <em>Aβ</em><sub>1–42</sub> oligomers (o<em>Aβ</em><sub>1–42</sub>). For that purpose, we investigate <em>ex vivo</em> CA3-CA1 synaptic plasticity, while <em>in vivo</em>, we performed open field habituation and social recognition tasks to assess contextual and social memory, respectively. Our data show that pharmacological activation of S1Rs with the selective agonist PRE-084 counteract o<em>Aβ</em><sub>1–42</sub> deleterious effects on CA3-CA1 long-term synaptic plasticity (LTP), and hippocampal-dependent contextual and social memory, without alterations of spontaneous behaviors. Together, these results provide further evidence for the role of S1Rs in ameliorating hippocampal synaptic and contextual memory dysfunctions and introduce novel insight into their involvement in early amyloid-induced social memory deficits, highlighting their potential for developing comprehensive treatments for early AD. Also, the absence of adverse behavioral outcomes associated with PRE-084 treatment suggests a favorable safety profile in preclinical models, supporting its potential as a therapeutic option.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"184 ","pages":"Article 117914"},"PeriodicalIF":7.5000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0753332225001088","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Sigma-1 receptors (S1Rs) are widely expressed throughout the central nervous system and modulate neuron intracellular calcium levels, leading to changes in neurotransmitter release and neuronal activity. They also interact with various proteins and signaling pathways, playing a key role in regulating synaptic plasticity in brain areas such as the hippocampus, thereby influencing learning and memory processes. This opens a research avenue to explore S1R modulation as a potential therapeutic target in diseases involving hippocampal synaptic alterations and compromised cognitive processes, such as Alzheimer's disease (AD). Here, we hypothesize that pharmacological activation of S1R could counteract synaptic plasticity deficits and hippocampal-dependent cognitive alterations in an early-stage amyloidosis model of Alzheimer’s disease, induced by intracerebroventricular (icv) administration of 1–42 oligomers (o1–42). For that purpose, we investigate ex vivo CA3-CA1 synaptic plasticity, while in vivo, we performed open field habituation and social recognition tasks to assess contextual and social memory, respectively. Our data show that pharmacological activation of S1Rs with the selective agonist PRE-084 counteract o1–42 deleterious effects on CA3-CA1 long-term synaptic plasticity (LTP), and hippocampal-dependent contextual and social memory, without alterations of spontaneous behaviors. Together, these results provide further evidence for the role of S1Rs in ameliorating hippocampal synaptic and contextual memory dysfunctions and introduce novel insight into their involvement in early amyloid-induced social memory deficits, highlighting their potential for developing comprehensive treatments for early AD. Also, the absence of adverse behavioral outcomes associated with PRE-084 treatment suggests a favorable safety profile in preclinical models, supporting its potential as a therapeutic option.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
由淀粉样蛋白-β低聚物引起的社会和情境记忆障碍可以通过Sigma-1受体激活来修复
Sigma-1受体(S1Rs)在整个中枢神经系统中广泛表达,并调节神经元细胞内钙水平,导致神经递质释放和神经元活性的变化。它们还与多种蛋白质和信号通路相互作用,在调节海马等大脑区域的突触可塑性中发挥关键作用,从而影响学习和记忆过程。这为探索S1R调节作为涉及海马突触改变和认知过程受损的疾病(如阿尔茨海默病(AD))的潜在治疗靶点开辟了研究途径。在这里,我们假设S1R的药理激活可以抵消脑室内(icv)给药Aβ1-42寡聚物(oAβ1-42)诱导的早期阿尔茨海默病淀粉样变模型中的突触可塑性缺陷和海马依赖的认知改变。为此,我们研究了离体CA3-CA1突触的可塑性,而在体内,我们分别进行了开放场习惯化和社会识别任务来评估情境记忆和社会记忆。我们的数据表明,选择性激动剂PRE-084对S1Rs的药理激活可以抵消oAβ1-42对CA3-CA1长期突触可塑性(LTP)和海马依赖的情境和社会记忆的有害影响,而不会改变自发行为。总之,这些结果为S1Rs在改善海马突触和情境记忆功能障碍中的作用提供了进一步的证据,并为它们参与早期淀粉样蛋白诱导的社会记忆缺陷提供了新的见解,突出了它们在开发早期AD综合治疗方面的潜力。此外,与PRE-084治疗相关的不良行为结果的缺失表明,在临床前模型中具有良好的安全性,支持其作为治疗选择的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.90
自引率
2.70%
发文量
1621
审稿时长
48 days
期刊介绍: Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.
期刊最新文献
Identifying novel biomarkers for systemic lupus erythematosus associated with macrophage activation syndrome Hedera helix-derived α−hederin (IVL-11) demonstrates both ex vivo and in vivo flukicidal activities against Fasciola hepatica Platelet extracellular vesicles drive monocyte differentiation into inflammatory foam cells in peripheral arterial disease Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2 Manipulation of tumor microenvironment by induction of immunogenic cell death and immune check point inhibitors for enhancing the efficacy of cancer treatments
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1